Acitretin-Conjugated Dextran Nanoparticles Ameliorate Psoriasis-like Skin Disease at Low Dosages

Psoriasis is a common chronic inflammatory skin disease mainly characterized by keratinocyte hyperproliferation and massive infiltration of inflammatory immune cells. Acitretin (ACT), an FDA-approved first-line systemic drug for psoriasis treatment, could suppress the proliferation of keratinocytes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Jiajia, Li, Yuce, Wen, Jingjing, Chen, Yu, Yang, Jing, Zhao, Liang, Xia, Yuting, Du, Hongyao, Tao, Juan, Li, Yan, Zhu, Jintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777251/
https://www.ncbi.nlm.nih.gov/pubmed/35071218
http://dx.doi.org/10.3389/fbioe.2021.816757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777251/
https://www.ncbi.nlm.nih.gov/pubmed/35071218
http://dx.doi.org/10.3389/fbioe.2021.816757

Ejemplares similares